Versatile and Efficient Protein Association Through Chemically Modified Sphingomyelin Nanosystems (SNs) for Enhanced
Marcelina Abal-Sanisidro1,2,3, Olaia Nieto-García1, Cristina Cotelo-Costoya1
1Nano-Oncology and Translational Therapeutics group, IDIS, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), 15706, Santiago de Compostela, Spain.
Chembiochem : a European Journal of Chemical Biology
|September 10, 2024
Summary
Sphingomyelin nanosystems (SNs) offer a novel solution for protein therapeutics delivery. These optimized systems enhance protein stability and bioavailability, paving the way for advanced drug development.
Area of Science:
- Biotechnology and Nanomedicine
- Protein Therapeutics Delivery
Background:
- Proteins are crucial for cellular signaling and therapeutic applications due to their specificity and activity.
- Challenges in protein therapeutics include instability, unfolding, and low bioavailability, hindering effective administration.
- Drug delivery systems and nanotechnology are explored to improve sustained release, bioavailability, and intracellular delivery of biomolecules.
Purpose of the Study:
- To optimize sphingomyelin nanosystems (SNs) for the delivery of a diverse range of proteins.
- To evaluate various chemical association strategies for protein loading within SNs.
- To validate the potential of SNs for developing advanced protein therapeutics.
Main Methods:
- Development and optimization of sphingomyelin nanosystems (SNs).
- Loading of various proteins (10-500 kDa, varying pI) using different chemical association strategies.
- Comprehensive characterization of SNs using diverse analytical methodologies.
- In vitro validation of the developed protein-loaded SN formulations.
Main Results:
- Successful optimization of sphingomyelin nanosystems (SNs) for protein encapsulation.
- Demonstrated ability of SNs to accommodate a wide range of protein sizes and isoelectric points (pI).
- In vitro studies confirmed the potential of SNs for effective protein delivery and bioactivity maintenance.
Conclusions:
- Sphingomyelin nanosystems (SNs) represent a promising platform for overcoming protein therapeutic delivery challenges.
- The developed SNs enhance protein stability, bioavailability, and intracellular delivery.
- This study provides evidence for the potential of SNs in the advancement of protein therapeutics.
Related Concept Videos
01:45Regulation of Nuclear Protein Sorting
2.5K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
01:43SNAREs and Membrane Fusion
10.4K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
10.4K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160